Companies: 10,795·Total market cap: $144.5T
Cybin Inc.

Cybin Inc.

CYBNAMEXHealthcare
$8.28
+$0.10(+1.22%)
Market Cap$413023556
P/E Ratio
52W High$10.7199
52W Low$4.81

Cybin Inc. (CYBN) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · CYBN · as of Sep 30, 2025

Ownership Breakdown

Institutions 18.49%
Insiders 22.71%
Public 58.8%

78

Institutional Holders

▲ 21 vs Q2

$54.31M

Total Inst. Value

▼ $15.27M vs Q2

49.88M

Shares Outstanding

freeFloat 77.29%

9.23M

13F Shares Held

▲ 930,307 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

CYBN largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

TANG CAPITAL MANAGEMENT LLC

pharmaceutical preparations

1.83M8.17%

8.17%

$10.78BNov 14, 2025— held

ROSALIND ADVISORS, INC.

pharmaceutical preparations

1.50M6.70%

6.70%

$8.84BNov 13, 2025 689.1K

POINT72 ASSET MANAGEMENT, L.P.

pharmaceutical preparations

1.24M5.53%

5.53%

$7.30BNov 14, 2025 366.7K

DEEP TRACK CAPITAL, LP

pharmaceutical preparations

1.00M4.46%

4.46%

$5.89BNov 14, 2025 530.0K

ACORN CAPITAL ADVISORS, LLC

pharmaceutical preparations

734.4K3.28%

3.28%

$4.31BNov 17, 2025— held

SPHERA FUNDS MANAGEMENT LTD.

pharmaceutical preparations

370.4K1.65%

1.65%

$2.18BNov 14, 2025 27.9K

UBS GROUP AG

pharmaceutical preparations

303.7K1.36%

1.36%

$1.79BNov 13, 2025 124.3K

DLD ASSET MANAGEMENT, LP

pharmaceutical preparations

280.0K1.25%

1.25%

$1.65BNov 14, 2025NEW

SUSQUEHANNA INTERNATIONAL GROUP, LLP

pharmaceutical preparations

273.8K1.22%

1.22%

$1.61BNov 14, 2025 248.9K

MORGAN STANLEY

pharmaceutical preparations

227.7K1.02%

1.02%

$1.34BMay 27, 2026 204.8K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

21

Increased

+1.87M shares

15

New Positions

first time holders

6

Decreased

−936.0K shares

0

Sold Out

fully exited

Net shares change (top 50)

+937.7K

+1.87M / −936.0K

Net new holders

+30

15 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

CYBN insider trading · insider activity

Source: SEC Form 4

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Cybin Inc. (CYBN) is primarily owned by institutional investors, who hold approximately 18.5% of total shares outstanding. Company insiders own approximately 22.71%, while retail and public investors account for the remaining 58.80%.

The largest institutional shareholder of Cybin Inc. is TANG CAPITAL MANAGEMENT LLC, holding approximately 1.83 million shares — equal to 8.17% of outstanding shares — as of September 30, 2025.

A total of 78 institutional investors currently hold CYBN stock, with a combined institutional value of approximately $54,313,985 as of the most recent 13F filing period.

Frequently asked questions

CYBN ownership

Cybin Inc. (CYBN) is primarily owned by institutional investors, who hold approximately 18.5% of shares. The largest shareholder is TANG CAPITAL MANAGEMENT LLC with a 8.17% stake. Company insiders hold 22.71%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns CYBN stockCYBN ownership structureSEC Form 13F institutional holdingsCYBN float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025